Explore / Clinical trial
Clinical trial

Psilocybin Therapy for Depression in Parkinson's Disease

Joshua Woolley, MD, PhDRecruitingPhase 2Started Aug 19, 202460 enrolledUnited StatesNCT06455293

Abstract

The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinDepression

Keywords

Parkinson DiseasePsilocybin therapyMovement disorderParkinson Disease

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.